Current evidence suggests that when CAR-T cells exert cytotoxic effects on tumor cells, the overproduction of proinflammatory cytokines, primarily IL-1, IL-6 and TNF-α, drives the development of CRS. Here, IL6 is linked to congenital rubella syndrome.